Nanexa AB
556833-0285ActiveNanexa redefines injectables using proprietary nanoengineering drug delivery technology.
Oversigt
- 10–19
- Medarbejdere
- 5–10mio SEK
- Omsætning
- 2010
- Grundlagt
Nøglebeslutningstagere
Anders Johansson
Head of Intellectual Property
David Westberg
Chief Executive Officer
Bridget Lacey
Chief Business Officer
Göran Ando
Chairman of the Board
+15 flere kontakter i Funnelfeedr
Beskrivelse
Nanexa is a pharmaceutical development company specializing in advanced drug delivery systems. Their core innovation is the proprietary PharmaShell® technology, which utilizes Atomic Layer Deposition (ALD) precision. This technology is designed to transform drug administration by enabling long-actin...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556833028501
Beslutningstagere
19 kontakter i FunnelfeedrAnders Johansson
Head of Intellectual Property
David Westberg
Chief Executive Officer
Bridget Lacey
Chief Business Officer
Göran Ando
Chairman of the Board
Marie Gårdmark
Director Regulatory Affairs
Cecilia Danckwardt-Lillieström
Chief Financial Officer
Bengt Gustavsson
Board Member
Polla Rouf
Head of R&D ALD
Sven Undeland
Director Strategic Market Analysis
Jonas Fransson
Head of Pharmaceutical Development
Mikael Asp
Head of Quality Assurance, Special Advisor
Jakob Dynnes Hansen
Board Member
Richard Davis
Board Member
Kristine Bäck
Director Project Management
Joel Hellrup
Head of Pharmaceutical R&D
Mårten Rooth
Chief Technology Officer, Co-founder
Hanna Tilus
Board Member
Birgit Stattin Norinder
Board Member
Björn Svanström
current CFO (leaving)
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
Iconovo AB
10–19 medarbejdereLeading partner developing patented dry powder inhaler drug delivery systems.
Double Bond Pharmaceutical AB
5–9 medarbejdereDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
AcroPharma AB (publ)
0 medarbejdereDeveloping innovative preventive therapeutics for major human diseases.
PILA PHARMA AB
1–4 medarbejdereClinical stage biotech developing an oral obesity and diabetes treatment.
Udforsk mere
Spørgsmål om Nanexa AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo